Palatin Technologies
PTN
#10364
Rank
A$29.9 M
Marketcap
A$16.81
Share price
-5.04%
Change (1 day)
11,999.62%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -A$7.94 Million

According to Palatin Technologies's latest financial reports the company's current earnings are A$8.84 Million. In 2024 the company made an earning of -A$38.14 Million, an increase over its 2023 earnings that were of -A$45.9 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$7.94 Million-79.2%
2024 -A$38.14 Million-16.9%
2023 -A$45.9 Million5.99%
2022 -A$43.31 Million-13.7%
2021 -A$50.18 Million33.25%
2020 -A$37.66 Million-172.11%
2019 A$52.21 M2352.33%
2018 A$2.12 M-94.13%
2017 A$36.28 M-154.92%
2016 -A$66.07 Million3.67%
2015 -A$63.73 Million878%
2014 -A$6.52 Million-72.64%
2013 -A$23.82 Million-33.11%
2012 -A$35.61 Million77.71%
2011 -A$20.04 Million
2003 -A$33.93 Million29.93%
2002 -A$26.12 Million36.18%
2001 -A$19.18 Million
1999 -A$15.92 Million6.04%
1998 -A$15.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.78 B-541,884.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$20.76 B-305,913.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
A$1.13 B-16,758.74%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-A$17 Million 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$0.23 B-3,513.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.17 Billion 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
A$0.13 B-2,097.69%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-A$41.75 Million 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-A$82.04 Million 1,108.36%๐Ÿ‡บ๐Ÿ‡ธ USA